Rotation Medical is a medical device company advancing the treatment of rotator cuff disease with the Rotation Medical Rotator Cuff Repair System, a commercially available solution with clinical evidence that demonstrates the ability to induce the growth of new tendinous tissue. Rotation's core technology combines a unique, proprietary bioinductive implant and a set of novel, arthroscopic disposable instruments that allow the procedure to be preformed quickly and reproducibly. The company received 510(k) clearance from the Food and Drug Administration (FDA) for its implantable bioinductive implant technology in March 2014.

Rotation Medical was acquired by Smith & Nephew plc in 2017 for $125 million in cash plus $85 million in potential milestone payments.